Home News Insights Trading halts Paper trading Guide Community My account

Market calendarNext market opening

Display in USD

Loading news article.

U.S. stock guide
Scanner guide
Paper trading guide
Terms of service
Privacy policy
Announcements
FAQ

Support: help@wapeb.comPartnerships: partnership@wapeb.com

WAPE is a free research, analysis and paper trading service. It does not place real securities orders. Market data and AI summaries are for information only, not investment advice or stock recommendations. Information may include delays, errors or estimates. Check original sources and supporting materials. You are responsible for your investment decisions and any resulting gains or losses.

Language한국어 English

Loading news article.

60 Degrees Pharmaceuticals Announces Partnership with The University of Southern Mississippi to Evaluate Castanospermine | WAPE

Back All news

Newsfiscal.ai

60 Degrees Pharmaceuticals Announces Partnership with The University of Southern Mississippi to Evaluate Castanospermine

Oct 30, 2026, 09:04 ET · Published

View source

Article summary

60 Degrees Pharmaceuticals has entered into a sponsored research agreement with The University of Southern Mississippi to assess the therapeutic potential of castanospermine in nonclinical models of alpha-gal syndrome.

An excerpt from the original article.

Related companies

60 Degrees Pharmaceuticals, Inc. Common StockSXTPView stock

60 Degrees Pharmaceuticals Announces Partnership with The University of Southern Mississippi to Evaluate Castanospermine

Article summary

Related companies

Analyzed by WAPE AI.

Comments —